Ayanchromium (Talk | contribs) |
Ayanchromium (Talk | contribs) |
||
Line 77: | Line 77: | ||
</ul> | </ul> | ||
</li> | </li> | ||
+ | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">Modelling</a></li> | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">Parts</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">Parts</a></li> | ||
− | + | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Collaborations">Collaborations</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Collaborations">Collaborations</a></li> | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Attributions">Attributions</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Attributions">Attributions</a></li> | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Human_Practices">Human Practices</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Human_Practices">Human Practices</a></li> | ||
− | <li class="hvr-underline-from-left"><a | + | <li class="hvr-underline-from-left"> |
− | href="https://2016.igem.org/Team:Example/Results"> | + | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">InterLab</a></li> |
+ | <a | ||
+ | href="https://2016.igem.org/Team:Example/Results">Special Prizes</a></li> | ||
</ul> | </ul> | ||
Revision as of 18:03, 18 October 2016
The purpose
Overview of our project
With the advent of rDNA technology...
With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1].
Read more
Our Bioreactor Design
We realized that manufacturing...
Collaboration
Indian iGEM meet
The SVCE Indian iGEM meet was held on 23rd July, 2016 at SVCE, Chennai, India.The morning session consisted of presentations by the IIT-Madras, IISc Bangalore and SVCE, each followed by a round of questions from an audience that consisted of SVCE faculty, students and, members of the iGEM teams.
Read more